NASDAQ:VKTX | Free Cash Flow | Viking Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$113.98M
2025-12-31-$85.29M
2025-03-31-$52.33M
2024-12-31-$31.18M
2024-03-31-$6.13M
2023-12-31-$17.64M
2023-03-31-$24.64M
2022-12-31-$10.93M
2022-03-31-$10.53M
2021-12-31-$12.35M
2021-03-31-$10.88M
2020-12-31-$5.49M
2020-03-31-$4.3M
2019-12-31-$11.74M
2019-03-31-$3.15M
2018-12-31-$2.68M
2018-03-31-$5.3M
2017-12-31-$3.95M
2017-03-31-$3.28M
2016-12-31-$2.46M
2016-03-31-$2.73M
2015-12-31-$3.3M
2015-03-31-$410,941.00
2014-12-31-$440,966.00
2014-03-31-$100,768.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$278.69M
2024-12-31-$87.79M
2023-12-31-$73.38M
2022-12-31-$48.4M
2021-12-31-$47.59M
2020-12-31-$21.78M
2019-12-31-$24.75M
2018-12-31-$18.76M
2017-12-31-$14.76M
2016-12-31-$11.07M
2015-12-31-$8.73M
2014-12-31-$1.59M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.